Drug Watch List

Note: Some of these drugs are not in trials yet or are not in trials that we are monitoring for GIST.
Note: Click on a column title to sort the list  

265 drugs found

Targets

Avastin
Genentech Bio-oncology
VEGF-A

Genentech/Amgen
DR4 (Death receptor 4)
DR5 (Death receptor 5)

Genentech/Exelixis
MEK

Genentech/Piramed Ltd.
PI3K
mTOR

Mekinist
GlaxoSmithKline
MEK1
MEK2

GlaxoSmithKline
KIT (pazopanib)
MEK (Trametinib)
VEGFRS (pazopanib)
PDGFRA (pazopanib)

GlaxoSmithKline

Tafinlar + Mekinist
GlaxoSmithKline
BRAF V600E
BRAF V600K
MEK 1/2

Votrient
GlaxoSmithKline
KIT
VEGFR-1, 2, 3
PDGFRA
PDGFRB
Itk
LCK
c-Fms
FGFR -1 and -3

Votrient + Hycamtin
GlaxoSmithKline
KIT (pazopanib)
PDGFRA (pazopanib)
PDGFRB (pazopanib)
VEGFRS (pazopanib)
Topoisomerase I (topetecan)

TAFINLAR
GlaxoSmithKline
BRAF
BRAF V600E
BRAF V600K

Votrient + Zolinza
GlaxoSmithKline & Merck
KIT (pazopanib)
PDGFRA (pazopanib)
PDGFRB (pazopanib)
VEGFRS (pazopanib)
HDAC (vorinostat)

Istodax
Gloucester Pharmaceuticals
HDAC

GSK
IGF1R

Hoffman-La Roche
gama-secretase

Hoffman-La Roche
PD-L1

Hoffman-La Roche

Hoffmann-La Roche
IGF1R

IDRx, Inc.
KIT V654A
PDGFRa V651D

Ignyta
TrkA
TrkB
TrkC
ROS1
ALK
NTRK

ImClone
IGF-1R

ImClone
IGF-1R (IMC-A12)
mTOR (CCI-779)

ImClone
PDGFRA

Intuvax
Immunicum
CD8 and CD4 positive T-cells

Incyte
IDO1

Incyte

Pemazyre
Incyte
FGFR2

Infinity
HSP90

Infinity
HSP90

Inhibrx, Inc.
DR5 (Death receptor 5)

Inhibrx, Inc.
DR5 (Death receptor 5)
DR5 (Death receptor 5)

Tyvyt
Innovent
PD-1

Insmed
IGF1R

ISA Pharmaceuticals

Rivoceranib
Jiangsu Hengrui Medicine
VEGFR2

Yondelis
Johnson & Johnson

Keryx
AKT

Kirin
IGF-1R

Kolltan
Kit

Kumquat Biosciences
SOS1

Komzifti
Kura Oncology Inc
Menie-MLL

Loxo Oncology
TrkA
TrkB
TrkC
NTRK

Medimmune
PD-L1
B7H1

MedImmune LLC
IGF1
IGF2
IGF-1R (indirectly)
IR-A (indirectly)

Zolinza
Merck
HDAC

Merck
IGF1R

Keytruda
Merck
PD-1

Merck
ATR

Zolinza + Nexavar
Merck + Bayer
KIT
PDGFRA
PDGFRB
BRAF
Mutant BRAF
CRAF
VEGFR
HDAC (vorinostat)

Merck + Incyte
PD-1
IDO1

Millenium
KIT
FLT3
PDGFRA

Millennium
KIT
FLT3
PDGFRB
PDGFRA (possible)

Velcade
Millennium
26S proteasome

Velcade + Sutent
Millennium
KIT (sunitinib)
PDGFRA (sunitinib)
PDGFRB (sunitinib)
VEGFRs (sunitinib)
RET (sunitinib)
SCF-1R (sunitinib)
CSF-1R (sunitinib)
26S proteasome (bortezomib)

Mundipharma-EDO Gmbh
Histone-deacetylase

Ningbo Newbay
KIT
PDGFRA

Tasigna
Novartis
DDR-1
DDR-2
Bcr-Abl
PDGFRA
PDGFRB
KIT
MAPK11
MAPK12
ZAK

Novartis
PI3K Class I
mTOR Raptor
mTOR Rictor

Gleevec
Novartis
KIT
bcr-abl
abl
PDGFRA
PDGFRB

Novartis
HSP90

Novartis
PI3K
mTOR

Farydak
Novartis
HDAC

Afinitor/Certican
Novartis
mTOR

Sandostatin
Novartis
SSTR

Novartis
SST-1
SST-2
SST-3
SST-5
Somatostatin receptors (SST-1, SST-2, SST-3, SST-5)

Novartis
PKC alpha
KIT
PDGFRA
PDGFRA (D842V)
VEGFR1
VEGFR2
VEGFR3
FLT3
PKC beta
PKC gamma
FGFR

Novartis
IGF-1R
FAK

Novartis
PKC theta
PKC alpha
PKC beta

Novartis
VEGFR1
VEGFR2
VEGFR3
KIT
PDGFRB

Gleevec
Novartis
KIT
Bcr-Abl
PDGFRA
PKC alpha
PKC beta
PKC gamma
VEGFR
FGFR
FLT3

Novartis
PI3K Class 1

Novartis
IGF1R

Tasigna + Gleevec
Novartis

Novartis
KIT
PDGFR
VEGFR1
VEGFR2
VEGFR3
FGFR1
FGFR2
FGFR3
FLT3
RET
TrkA
CSF-1R

Novartis
PI3K Class 1A

Novartis
MEK 1/2

Novartis
PI3K Class 1A
MEK 1/2

Novartis
PI3K Class 1
mTOR Raptor
mTOR Rictor
MEK 1/2

Novartis
PI3K Class 1
MEK 1/2

Novartis
KIT (Gleevec)
PDGFRA (Gleevec)
Bcr-Abl (Gleevec)
PI3K (BKM120)

Novartis

Novartis

Novartis
FGFR
FGFR1
FGFR2
FGFR3
VEGFR2

Novartis
KIT (imatinib)
FGFR

Gleevec + Dovitinib
Novartis

Novartis
KIT

Novartis
PD-1

Novartis

Novartis
KIT
PD-1

Novartis
FGFR
FGFR1
FGFR2
FFGFR3
KIT
PDGFRA
VEGFR2

Glivec + Stivarga
Novartis + Bayer

Novartis + Bristol Myers-Squibb
CTLA-4 (ipilimumab)
KIT (imatinib)

Gleevec + Genasense
Novartis + Genta
KIT (Gleevec)
PDGFRA (Gleevec)
Bcr-Abl (imatinib)
Bcl-2 (Genasense)

Novartis + GlaxoSmithKline
MEK 1/2
PI3K Class 1A

Gleevec
Novartis + Keryx
KIT
AKT
PDGFRA
Bcr-Abl

Gleevec + Proleukin
Novartis + Novartis
KIT (Gleevec)
Bcr-Abl (imatinib)
PDGFRA (Gleevec)
Interleukin-2 (IL-2)

Gleevec, Tasigna
Novartis + Novartis
Both have similar targets
KIT
Bcr-abl
PDGFRA
PDGFRB

Gleevec
Novartis + Novartis
HDAC
KIT
PDGFRA
PDGFRB
Bcr-Abl

Gleevec + Avastin
Novartis and Genentech
KIT (imatinib)
VEGFR (bevacizumab)
PDGFRA (imatinib)
PDGFRB (imatinib)
Bcr-Abl (imatinib)

Gleevec + Afinitor
Novartis, Novartis
KIT
PDGFRA
Bcr-Abl
mTOR

Gleevec, Sutent
Novartis, Pfizer
KIT (imatinib & sunitinib)
PDGFRA (imatinib & sunitinib)
Bcr-Abl (imatinib)
VEGFR1 (sunitinib)
VEGFR2 (sunitinib)
VEGFR3 (sunitinib)
FLT3 (sunitinib)
CSR-1R (sunitinib)
RET (sunitinib)

Gleevec + PEG-Intron
Novartis, Schering
KIT
PDGFRA
Bcr-Abl

Novartis/Vernalis
Hsp90

Novelty Nobility
KIT

Oncothyreon
HIF-1α

Oncothyreon
PI3K Class I

OSI
KIT
VEGFR

OSI
IGF1R
IR (insulin receptor)

Peloton
HIF-2a

Sutent
Pfizer
KIT
PDGFRA
PDGFRB
VEGFR1
VEGFR2
VEGFR3
FLT3
CSF-1R
RET

Pfizer
IGF1R

Inlyta
Pfizer
VEGFR-1, 2, 3
KIT
PDGFRA
T315I (BCR-ABL gatekeeper mutation)

Pfizer

Pfizer

Campostar
Pfizer

Pfizer

Ibrance
Pfizer
Cdk4
Cdk6

Talzenna
Pfizer
PARP1
PARP2

Pfizer
PD-L1
KIT

Taxol
Pfizer
Tubulin

265 drugs found